Synergistic Therapeutic Effects of Duzhong Jiangya Tablet Combined with Amlodipine Besylate on Spontaneously Hypertensive Rats Using 1 H-NMR and MS Based Metabolomics.
Duzhong Jiangya Tablet (DJT) composed of Eucommia ulmoides Oliv and several other traditional Chinese medicines is a Chinese herbal compound, which is clinically used to treat hypertension. The aim of this study was to evaluate the antihypertensive effect of DJT and amlodipine besylate (AB) on the synergistic treatment of spontaneously hypertensive rats (SHR), and to explore its antihypertensive mechanism. The synergistic therapeutic effect of DJT in combination with AB on SHR was studied using two metabolomics methods based on MS and NMR. Metabolomics analysis of plasma, urine, liver and kidney and the combination of OPLS-DA to expose potential biomarkers. Then the overall metabolic characteristics and related abnormal metabolic pathways in hypertensive rats were constructed. Blood pressure measurements showed that DJT combined with AB has better effects in treating hypertension than it being alone. A total of 30 biomarkers were identified, indicating that hypertension disrupted the balance of multiple metabolic pathways in the body, and that combined administration restored metabolite levels better than administration alone. The changes of biomarkers revealed the synergistic therapeutic mechanism of DJT combined with AB, which provided a reference for the combination of Chinese and Western medicines.